Delcath (DCTH) Enters CHEMOSAT Launch Agreement with INT in Naples, Italy
Tweet
Share
E-mailGet Alerts DCTH Hot Sheet
Join SI Premium – FREE
Delcath Systems, Inc. (Nasdaq: DCTH) has entered into an initial launch and training agreement for the Delcath Hepatic CHEMOSAT Delivery system with the Istituto Nazionale Tumori Fondazione G. Pascale in Naples, Italy. The center pursues both clinical and applied research in cancer treatment and is Southern Italy's largest Scientific Institute for Research, Hospitalization and Health Care (IRCCS) in oncology.
The CHEMOSAT program at G. Pascale will be led by Paolo Ascierto, MD, medical oncologist and Prof. Nicola Mozzillo, MD, surgical oncologist. Drs. Ascierto and Mozzillo are both directors in the center's department of melanoma, soft tissues, musculo-skeletal and head and neck.
Under the terms of the agreement, Delcath will provide G. Pascale with logistics and clinical training support in the performance of chemosaturation therapy using the CHEMOSAT system. Training is expected to take place in May.
The CHEMOSAT program at G. Pascale will be led by Paolo Ascierto, MD, medical oncologist and Prof. Nicola Mozzillo, MD, surgical oncologist. Drs. Ascierto and Mozzillo are both directors in the center's department of melanoma, soft tissues, musculo-skeletal and head and neck.
Under the terms of the agreement, Delcath will provide G. Pascale with logistics and clinical training support in the performance of chemosaturation therapy using the CHEMOSAT system. Training is expected to take place in May.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Gray Media closes $750M note offering to refinance higher-rate debt
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
